Skip to main content
ILDONG HOLDINGS CO.,LTD logo

ILDONG HOLDINGS CO.,LTD — Investor Relations & Filings

Ticker · 000230 ISIN · KR7000230003 KO Manufacturing
Open in API
Filings indexed 368 across all filing types
Latest filing 2026-05-29 Governance Information
Country KR South Korea
Listing KO 000230

About ILDONG HOLDINGS CO.,LTD

https://www.ildongholdings.com

ILDONG HOLDINGS CO.,LTD. is a holding company that manages a diversified healthcare group. Its primary subsidiary, Ildong Pharmaceutical, develops, manufactures, and supplies a broad portfolio of pharmaceutical products, including over-the-counter drugs, vitamins, and antibiotics. The pharmaceutical division maintains a robust R&D pipeline focused on treating metabolic disorders, gastrointestinal diseases, and degenerative conditions. Other key subsidiaries include ILDONG BIOSCIENCE, a specialist in probiotics and functional health foods, and Ildong Healthcare, which provides healthy-lifestyle products such as water ionization units. The group collectively aims to enhance human health through its diverse offerings in pharmaceuticals, bioscience, and consumer healthcare.

Recent filings

Filing Released Lang Actions
기업지배구조보고서공시
Governance Information Classification · 95% confidence The document is a detailed Corporate Governance Report (“기업지배구조 보고서”) including governance policies, board composition, shareholder meeting procedures, and compliance with key governance indicators. It is not a brief announcement or proxy statement but the substantive governance report itself. This matches the “Governance Information” category (CGR).
2026-05-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 85% confidence The document is a Korean "주식등의 대량보유상황보고서(일반)" submitted under the Capital Markets Act to disclose changes in significant shareholdings (including beneficial ownership, pledges, related parties, share counts before/after), clearly matching a major shareholding notification. It is neither an earnings release nor an interim/annual report but a regulatory insider/shareholding change filing. Therefore, it falls under Major Shareholding Notification (MRQ).
2026-05-21 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is titled “분기보고서” (Quarterly Report) for the 84th fiscal period covering January 1, 2026 to March 31, 2026. It contains comprehensive interim financial statements, detailed company overview, business segments, capital changes, share counts, and other substantive data—indicating this is the actual quarterly report itself. It is not merely an announcement or an officer certification but the full interim disclosure. Therefore, it matches the definition of an Interim/Quarterly Report (IR). Q1 2026
2026-05-15 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 85% confidence The document is a Korean ‘공정공시’ preliminary disclosure of consolidated financial results for the quarter ended March 31, 2026, showing revenue, operating profit, net profit and related metrics. It provides key highlight figures rather than a full set of statements or detailed MD&A. This matches an initial quarterly earnings announcement rather than a full interim report or other filing. Therefore, it should be classified as an Earnings Release. Q1 2026
2026-05-13 Korean
결산실적공시예고(안내공시)
Report Publication Announcement Classification · 87% confidence The document is a brief notice (“안내공시”) stating that IlDong Holdings will publish its quarterly financial results for the period 2026-01-01 to 2026-03-31 on 2026-05-13. It contains no actual financial data, only the scheduled publication date of the report, making it a report publication announcement rather than the report itself.
2026-05-11 Korean
회사합병결정(종속회사의주요경영사항)
M&A Activity Classification · 90% confidence The document is a formal announcement detailing a decision to merge a wholly owned subsidiary (합병) into the parent company, including merger method, ratio, schedule, and legal bases. This is clearly an M&A transaction disclosure rather than a financial report, earnings release, or governance policy. Thus it falls under M&A Activity (TAR).
2026-04-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.